Abeona Therapeutics Statistics

Total Valuation

LON:0H7R has a market cap or net worth of GBP 227.83 million. The enterprise value is 183.16 million.

Market Cap	227.83M
Enterprise Value	183.16M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	51.16M
Shares Outstanding	n/a
Shares Change (YoY)	+94.57%
Shares Change (QoQ)	+2.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	7.11
P/TBV Ratio	7.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.36
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.76

Financial Position

The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.58.

Current Ratio	4.90
Quick Ratio	4.77
Debt / Equity	0.58
Debt / EBITDA	n/a
Debt / FCF	-0.38
Interest Coverage	-16.36

Financial Efficiency

Return on equity (ROE) is -271.78% and return on invested capital (ROIC) is -109.23%.

Return on Equity (ROE)	-271.78%
Return on Assets (ROA)	-49.95%
Return on Invested Capital (ROIC)	-109.23%
Return on Capital Employed (ROCE)	-85.53%
Revenue Per Employee	n/a
Profits Per Employee	-251,461
Employee Count	136
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.63% in the last 52 weeks. The beta is 1.55, so LON:0H7R's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	+29.63%
50-Day Moving Average	5.73
200-Day Moving Average	5.77
Relative Strength Index (RSI)	48.77
Average Volume (20 Days)	6,982

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.60

Income Statement

Revenue	n/a
Gross Profit	-28.71M
Operating Income	-53.88M
Pretax Income	-34.20M
Net Income	-34.20M
EBITDA	-52.29M
EBIT	-53.88M
Earnings Per Share (EPS)	-0.73

Full Income Statement

Balance Sheet

The company has 65.14 million in cash and 18.56 million in debt, giving a net cash position of 46.58 million.

Cash & Cash Equivalents	65.14M
Total Debt	18.56M
Net Cash	46.58M
Net Cash Per Share	n/a
Equity (Book Value)	32.04M
Book Value Per Share	0.65
Working Capital	54.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -46.35 million and capital expenditures -2.42 million, giving a free cash flow of -48.76 million.

Operating Cash Flow	-46.35M
Capital Expenditures	-2.42M
Free Cash Flow	-48.76M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0H7R does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-94.57%
Shareholder Yield	n/a
Earnings Yield	-15.01%
FCF Yield	-21.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 5, 2022. It was a reverse split with a ratio of 0.04.

Last Split Date	Jul 5, 2022
Split Type	Reverse
Split Ratio	0.04

Scores

Altman Z-Score	n/a
Piotroski F-Score	1